A first of its kind treatment for babies as young as eight months who have cryopyrin-associated periodic syndromes (CAPS) has just been licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) for use in the UK.
The European Commission has granted approval to Revlimid (lenalidomide) for the treatment of patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are failing.
The debate over a pharmacy law that forces patients away from GPs who dispense pharmaceuticals is heating up in the House of Lords with a series of questions from five peers to Earl Howe, England’s pharmacy minister.
Nutricia, a division of Danone, has just launched Souvenaid for people who are in the early stages of Alzheimer’s Disease. Souvenaid is a ‘Food for Special Medical Purposes’ that is loaded with the nutrients needed to maintain healthy synapses.